[{"Assets_0_Q1_USD":306659000.0,"CommonStockSharesOutstanding_0_Q1_shares":14214000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":8462000.0,"NetIncomeLoss_1_Q1_USD":4507000.0,"StockholdersEquity_0_Q1_USD":269071000.0,"EarningsPerShareBasic_1_Q1_USD":0.32,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":14185000.0,"Ticker":"ANIK","CIK":"898437","name":"ANIKA THERAPEUTICS, INC.","OfficialName":"Anika Therapeutics Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"337949354.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20190506"}]